Acute myeloid leukemia therapeutics: CARs in the driver’s seat

Acute myeloid leukemia remains a difficult disease to cure and novel therapeutic approaches are needed. To this end, we developed CD123 chimeric antigen receptor (CAR) redirected T cells which exhibited potent antileukemic activity. We discuss what we learned during the development of CD123 CARs and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mardiros, Armen, Brown, Christine E, Budde, L Elizabeth, Wang, Xiuli, Forman, Stephen J
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Author's View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916356/
https://ncbi.nlm.nih.gov/pubmed/24511454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27214
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars